17 September, 2017
The correct version of this report can be viewed at https://www.equitiesfocus.com/2017/09/17/insider-selling-pfizer-inc-pfe-insider-sells-1338050-00-in-stock.html. About 55,911 shares traded or 119.64% up from the average.
The stock decreased 0.12% or $0.14 on September 15, reaching $118.12. Advantage Investment Management LLC lifted its stake in shares of Pfizer by 1.7% during the 1st quarter. Asset Planning Services Ltd. now owns 2,961 shares of the biopharmaceutical company's stock valued at $101,000 after acquiring an additional 137 shares in the last quarter. Institutional investors and hedge funds own 69.09% of the company's stock. Lakeview Capital Partners Llc who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $210.57B market cap company. The stock was sold at an average price of $32.70, for a total transaction of $263,692.80. About 28.87 million shares traded or 67.95% up from the average.
Shares of Pfizer (NYSE PFE) opened at 35.36 on Wednesday. It has underperformed by 19.46% the S&P500. The firm's revenue for the quarter was down 3.0% on a year-over-year basis. Therefore 35% are positive.
PFE has been the subject of several analyst reports. (NYSE:PFE) earned "Buy" rating by Piper Jaffray on Friday, August 14. The company was maintained on Saturday, September 5 by Piper Jaffray. The rating was upgraded by SunTrust on Wednesday, November 25 to "Neutral".
Jefferies Group LLC set a $34.00 price target on Pfizer, Inc. (NYSE:PFE) rating on Friday, April 7. The rating was maintained by JP Morgan with "Neutral" on Tuesday, May 31. The stock of Pfizer Inc. (NYSE:PFE) earned "Buy" rating by Jefferies on Thursday, August 4. (NYSE:PFE) for 225,905 shares. Pfizer, Inc. The firm has a 50-day moving average of $33.64 and a 200 day moving average of $33.53. (NYSE:PFE) has "Buy" rating given on Monday, June 20 by Jefferies. Berenberg initiated Pfizer Inc. (NYSE:PFE). Massachusetts-based Excalibur has invested 5.3% in Pfizer Inc. They expect $0.64 EPS, up 4.92% or $0.03 from last year's $0.61 per share. ERIE's profit will be $58.07 million for 26.60 P/E if the $1.11 EPS becomes a reality. Birmingham Cap Mngmt Company Inc Al reported 179,987 shares.
Investors sentiment decreased to 1.13 in 2016 Q4. Its down 0.01, from 0.95 in 2016Q3. 115 funds opened positions while 711 raised stakes. Moreover, Messner & Smith Theme Value Investment Management Ltd Ca has 1.96% invested in the company for 10,646 shares. The New York-based Hap Trading Ltd Liability Co has invested 0.06% in Pfizer Inc. (NYSE:PFE). Timber Creek Limited Liability Com reported 33,478 shares. Cramer Rosenthal Mcglynn Lc reported 52,659 shares or 0.03% of all its holdings. It also reduced Ishares Tr (INDA) stake by 2.34 million shares and now owns 177,450 shares. Pfizer makes up approximately 0.6% of Mizuho Securities USA LLC's investment portfolio, making the stock its 7th biggest position. Stockholders of record on Friday, August 4th were given a dividend of $0.32 per share. Guardian Advsr Limited Partnership owns 0.66% invested in Pfizer Inc. Mckinley Carter Wealth stated it has 28,244 shares. Willingdon Wealth Mgmt invested in 1% or 65,119 shares. Meridian Counsel stated it has 62,146 shares or 1.35% of all its holdings. (NYSE:PFE). Shell Asset Mngmt owns 1.20 million shares or 1.05% of their United States portfolio. Churchill Corporation reported 534,707 shares.
Blackrock Advisors Llc, which manages about $98.75 billion US Long portfolio, decreased its stake in Spire Inc by 162,971 shares to 51,425 shares, valued at $3.32 million in 2016Q4, according to the filing. Integral Derivatives Ltd Co holds 15,692 shares. Rodgers Brothers invested in 43,417 shares or 0.55% of the stock. Cowen & Co maintained it with "Buy" rating and $4300 target in Monday, July 10 report. (NYSE:PFE) news were published by: Fool.com which released: "The case for AbbVie" on August 21, 2017, also Seekingalpha.com with their article: "Recent Buy: Pfizer Inc." published on September 14, 2017, Seekingalpha.com published: "Pfizer Looks To Sneak In the Market Before Heavy Hitters" on August 18, 2017. More interesting news about Pfizer Inc. (NYSE:PFE). Fcm Investments Tx holds 30,530 shares or 0.6% of its portfolio.
Fishman Jay A Ltd decreased The Blackstone Group L.P. (NYSE:BX) stake by 36,400 shares to 487,504 valued at $13.18M in 2016Q4. The Hl Financial Services Llc holds 3.08M shares with $100.02M value, up from 2.95M last quarter. Zacks Investment Research upgraded shares of Pfizer from a "sell" rating to a "hold" rating in a research note on Friday, July 14th. Therefore 92% are positive. Pfizer had 55 analyst reports since July 29, 2015 according to SRatingsIntel. Morgan Stanley reissued a neutral rating and set a $35.00 target price (down previously from $38.00) on shares of Pfizer in a research report on Monday, June 12th. The firm has "Neutral" rating by Goldman Sachs given on Monday, April 18. The stock presently has an average rating of "Hold" and a consensus target price of $37.72. RBC Capital Markets maintained Monsanto Company (NYSE:MON) rating on Tuesday, September 5. The rating was downgraded by Jefferies to "Hold" on Thursday, October 13. The firm has "Underperform" rating given on Friday, September 11 by Bernstein. The rating was maintained by Robert W. Baird on Thursday, April 28 with "Outperform". The rating was maintained by Monness Crespi with "Buy" on Monday, October 3. Canaccord Genuity maintained Paypoint plc (LON:PAY) on Thursday, November 26 with "Buy" rating.
More notable recent Monsanto Company (NYSE:MON) news were published by: Blogs.Wsj.com which released: "Monsanto Financing and Integration Await New Bayer CFO" on September 12, 2017, also Bloomberg.com with their article: "Bayer Faces In-Depth EU Review of $66 Billion Monsanto Deal" published on August 22, 2017, Reuters.com published: "Monsanto fights to sell Arkansas farmers herbicide linked to crop damage" on September 07, 2017.
